FDA Webview
X

Free FDA Notices

OMB OKs Info on Orphan Products Development

06/03/2015

Federal Register Notice: FDA’s collection of information entitled, “Guidance for Industry, Researchers, Patient Groups, and FDA Staff on Meetings with the Office of Orphan Products Development,” has been approved by the Office of Management and Budget under the Paperwork Reduction Act of 1995. To view this notice, click here.

LATEST NEWS